Clinical Impact of Genetic Testing in Inherited Kidney Diseases

Clicks: 1
ID: 314064
2026
Free PDF
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This article has not been analysed, so there is no overall score — reader engagement is measured and shown alongside.
AI Quality Assessment
Not analyzed
Readership in this journal

Ranked #83 of 127 articles by views in clinical kidney journal

Most read Least read

Bar heights use a square-root scale. Only the 120 most-read articles are drawn; the journal has 127 in total.

Mint this article as an NFT
Not yet minted

Create a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.

5 SUSD one-off · no wallet required
Sign in to mint
Abstract
Abstract Background Inherited kidney diseases (IKDs) and congenital anomalies of the kidney and urinary tract (CAKUT) are a clinically heterogeneous subset of chronic kidney disease (CKD) and rank among the leading causes of kidney failure (KF), especially in younger patients. Although next-generation sequencing has expanded diagnostic opportunities, data linking genetic findings to clinical outcomes across both adults and children remain limited. Methods We enrolled 256 patients with suspected IKD (175 adults, 81 children) at a single tertiary center between 2020–2023. Genetic testing was performed using targeted panels or exome sequencing (ES), including CNV and MUC1 analyses. Clinical data, including family history, proteinuria, hematuria, extrarenal manifestations, and kidney survival, were systematically assessed. Results Pathogenic variants were identified in 38.7% of patients. Five genes (PKD1, PKD2, COL4A5, COL4A4, and HNF1B) accounted for 62.6% of solved cases. Diagnostic yield was highest in cystic kidney diseases (72.0%), followed by tubulopathies (34.3%), glomerulopathies (25.8%), and CAKUT (19.2%). Multivariable regression identified positive family history, extrarenal manifestations, and arterial hypertension as predictors of a genetic diagnosis, with tubular proteinuria serving as an additional predictor in children. Kidney survival varied substantially across genetic subgroups: patients with PKD2 variants and tubulopathies showed more favorable outcomes, whereas individuals with COL4A5-associated Alport syndrome and glomerulopathies progressed rapidly. In the overall cohort, females reached 50% KF significantly later than males. Genetically solved men had the poorest outcomes, with a significant difference compared with solved women; however, this difference was reduced to a non-significant trend after excluding X-linked disorders. Conclusions Genetic testing provided clinically relevant diagnoses in nearly 40% of patients with suspected IKD, enabling more accurate prognostication and patient stratification. High yield in cystic disease and pediatric tubular proteinuria, sex-specific survival differences, and CNV analysis highlight the value of integrating genetics into routine nephrology care to guide diagnosis, management, and family counselling.
Reference Key
openalex_W7161631824 Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors Lea M Merz, Sarah Stopp, Ilona Krey, Fabian Baalmann, Emilia Marczak, Nora Liebmann, Olga Hempel, Bastian M Krüger, Marie Engesser, Anne-Christin Teichmann, Franziska Schnabel, Rami A Jamra, Johannes Lemke, Carsten Bergmann, Tom H Lindner, Jonathan de Fallois, Johannes Münch, Jan Halbritter, Katalin Dittrich, Friederike Petzold
Journal clinical kidney journal
Year 2026
DOI
10.1093/ckj/sfag160
URL
https://doi.org/10.1093/ckj/sfag160
Keywords Keywords not found

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

Comments

No comments yet. Be the first to comment on this article.